Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 01, 2006 (Vol. 26, No. 19)

Cancer Immunome Database

URL:www.2.licr.org/cancerimmunomedb
  • Database
  • Relatively narrow focus
If you want to check out this site, you’ll have to go through their free registration process. I think you’ll find it worth your while. Covering the human immunome, the Cancer Immunome Database focuses on gene products against which an immune response is known in cancer patients. A searchable database with selectable criteria that include options for patient ID, tissue, cancer type, serum info, sequence ID, and more is available. Other data available include that from microarrays, methylation analysis, and immunostaining. Other sections appeared to be under construction. Users can also compare sequences at this site. While the site appears to be focused tightly on researchers in this area, it appears to be serving them well.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »